Genetic tests for common diseases: new insights, old concerns.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

18 citing papers in PubMed.

1. The Provision of Genetic Testing and Related Services in Quebec, Canada.Frontiers in genetics · 2020
   Article
2. A tiered-layered-staged model for informed consent in personal genome testing.European journal of human genetics : EJHG · 2013
   Article
3. A novel major histocompatibility complex locus confers the risk of premature coronary artery disease in a Chinese Han population.Molecular biology reports · 2013
   Article
4. Genomics and successful aging: grounds for renewed optimism?The journals of gerontology. Series A, Biological sciences and medical sciences · 2012
   Review
5. Misuse (and abuse?) of the Concept of Empowerment.The Case of Online Offer of Predictive Direct-to-consumer Genetic Tests.Journal of public health research · 2012
   Article
6. Personal genome testing: test characteristics to clarify the discourse on ethical, legal and societal issues.BMC medical ethics · 2011
   Review
7. Preconceptional genetic carrier testing and the commercial offer directly-to-consumers.Human reproduction (Oxford, England) · 2011
   Article
8. Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disorders.European journal of human genetics : EJHG · 2011
   Review
9. Family history in primary care: understanding GPs' resistance to clinical genetics--qualitative study.The British journal of general practice : the journal of the Royal College of General Practitioners · 2010
   Article
10. Negotiating the boundary between medicine and consumer culture: online marketing of nutrigenetic tests.Social science & medicine (1982) · 2010
    Article
11. Perceived age as clinically useful biomarker of ageing: cohort study.BMJ (Clinical research ed.) · 2009
    Article
12. Using lifetime risk estimates in personal genomic profiles: estimation of uncertainty.American journal of human genetics · 2009
    Article
13. Genetics and the general physician: insights, applications and future challenges.QJM : monthly journal of the Association of Physicians · 2009
    Review
14. Genome paths: a way to personalized and predictive medicine.Acta naturae · 2009
    Article
15. Planning for translational research in genomics.Genome medicine · 2009
    Article
16. Genetic horoscopes: is it all in the genes? Points for regulatory control of direct-to-consumer genetic testing.European journal of human genetics : EJHG · 2009
    Article
17. Testing challenges: evaluation of novel diagnostics and molecular biomarkers.Clinical medicine (London, England) · 2009
    Article
18. Evaluating laboratory diagnostic tests.BMJ (Clinical research ed.) · 2008
    Article

Corrections and comments

• Commented on by
  Evaluating laboratory diagnostic tests.2008

Authors and funding

6 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as